• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Date 10/12/2022
Event Type  Injury  
Manufacturer Narrative
The model description of tjf-260v and jf-260v was same.One of representative product was chosen for processing purposes.The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled, "endoscopic bridge-and-seal of bile leaks using a fully covered self-expandable metallic stent above the papilla".Background/aims: endoscopic management by endoscopic sphincterotomy with or without plastic stents or fully covered self-expandable metallic stents (fcsemss) is widely accepted as the current standard of care for postoperative bile leaks.Biliary stents are placed across the papilla, not above the papilla.We investigated the safety and effectiveness of the bridge-and-seal technique for bile leaks by the placement of fcsems above the papilla.Methods: this was a retrospective study of fcsems placement above the papilla for bile leaks between (b)(6) 2016 and (b)(6) 2021.Fcsems was placed above the papilla to bridge and seal the leak.The main outcome measures were the resolution of bile leaks and adverse events.Results: seven patients with postoperative bile leaks underwent fcsems above the papilla.The locations of bile leaks were 1 cystic duct remnant; 2 intrahepatic bile duct; 1 hepatic duct; 2 common bile duct and 1 anastomosis.The technical success rate of fcsems placement was 100%, and resolution of bile leaks was achieved in five patients (71.4%).All the adverse events were observed after fcsems removal; as follows: 1 moderate cholangitis; 2 mild post-ercp pancreatitis; and 1 mild remnant cholecystitis.Conclusions: fcsems placement above the papilla can be a treatment option for postoperative bile leaks.Type of adverse events/number of patients: patient of case 2 with pancreatitis, patient of case 3 with cholangitis and pancreatitis, patient of case 6 with remnant cholecystitis.This literature article requires 3 reports.The related patient identifiers are as follows: 1, (b)(6) (tjf-260v for case 2), 2, (b)(6) (tjf-260v for case 3), 3, (b)(6) (tjf-260v for case 6).This medwatch report is for patient identifier: (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16287386
MDR Text Key308706149
Report Number9610595-2023-01712
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/05/2023
Initial Date FDA Received02/02/2023
Supplement Dates Manufacturer Received03/02/2023
Supplement Dates FDA Received03/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age25 YR
Patient SexMale
-
-